Press Release Contact

Press release:
RBI Granted 'Fast Track' Designation by FDA, Validating Its Direct-to-Brain Stem Cell Therapy for Alzheimer's Disease
June 15, 2026, 12:00 GMT

For questions about this press release, please contact the person or organization listed below.

Robert Lynn
Regeneration Biomedical, Inc.
+1 877-240-1660
Visit us on social media:
LinkedIn
Instagram
Facebook
X